James Bussel, MD, discusses why individualized care and thoughtful testing are important for developing effective immune thrombocytopenia treatment plans.
Transcript
In my experience, a red flag for a care plan that would not work as well as it could or should, would be one of several things:
If there was no individualization in the sense that it did not take into account patient-related factors that might be very important in the approach.
If it does not have or has an absolute minimum of blood tests, or other tests, to try to determine what type of ITP this is.
And that’s relevant to the idea that while And that’s relevant to the idea that while relatively little is mandated for all patients, I think there are things that make a great deal of sense to do for certain patients in certain age categories, gender categories, with certain types of problems, and completely ignoring those would, in my mind, be a red flag.
